Urogen Pharma Ltd (URGN)

Investing Cash Flow

$40.10M

TTM · Period ending: · USD

URGN logo

URGN Investing Cash Flow

Latest reported$40.10M
URGN TTM Cash from Investing (-$793.00K → $40.10M)
High-resolution chart · PNG

URGN investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
40,100,000
66,833,000
61,558,000
94,462,000
-43,686,000
-60,094,000
-20,613,000
-92,578,000
14,573,000
6,295,000
-953,000
33,499,000
-1,421,947
-5,292,947
2,033,053
-11,949,947
33,230,000
2,641,000
4,069,000
44,409,000
46,983,000
95,237,000
93,238,000
53,069,000
27,176,000
-132,524,000
-145,593,000
-154,915,000
-142,589,000
-586,000
35,287,000
-841,000
-628,000
-466,000
-36,377,000
-344,000
-355,000
-730,000
-793,000
-740,000
-800,000
-392,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.